论文部分内容阅读
作者报告了在乌干达癌症研究所用阿霉素(Adriamycin)治疗了14例肝细胞癌。所有患者均经肝活检证实。按1971年7月坎帕拉肝细胞癌国际讨论会拟订的肝细胞癌的功能-解剖分级标准,属Ⅰ级者2例,Ⅱ级者3例,Ⅲ级者9例。用药方法为阿霉素75毫克/平方米,静注,每3周1次。14例中除3例因较早死亡而未用足够药物外,其余11例均接受了至少2个疗程的阿霉素治疗。这11例均获得良好反应,其中3例分别在阿霉素治疗第2、3和5个疗程后肿瘤完全退缩,血清甲胎蛋白转阴,其缓解期分别为3、6和
The authors reported on the treatment of 14 hepatocellular carcinomas with Adriamycin at the Uganda Cancer Institute. All patients were confirmed by liver biopsy. According to the July 1971 Kampala hepatocellular carcinoma developed by the International Symposium on the function of hepatocellular carcinoma - anatomical grading standards, there are 2 cases of grade Ⅰ, Ⅱ grade in 3 cases, Ⅲ grade in 9 cases. Medication method for doxorubicin 75 mg / square meters, intravenous injection, once every 3 weeks. Of the 14 patients, except for 3 cases who did not have adequate medication due to earlier death, the remaining 11 patients received at least 2 courses of doxorubicin treatment. All 11 cases received good response. Three of them showed complete tumor regression after the second, the third and the fifth courses of doxorubicin treatment. The serum alpha-fetoprotein was negative. The remission period was 3, 6 and